Frazier Life Sciences Management, L.P.

Position in EOLS — Evolus, Inc.

CIK 1892134 PALO ALTO, CA

Back to EOLS Full portfolio

Position in EOLS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$18,256,815

+$7,444,782 QoQ

Shares Held

2,630,665

0.0% QoQ

Ownership

3.98%

of shares outstanding

% of Portfolio

0.40%

of 13F equity value

Holder Rank

of 157 holders

Holding Since

Jun 2025

5 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in EOLS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Frazier Life Sciences Management, L.P. holds $95,063,117 across 3 Drug Manufacturers - Specialty & Generic names. EOLS ranks #3 (19.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BCRX	Biocryst Pharmaceuticals Inc	4,009,240	$40,092,400
2	ALKS	Alkermes plc.	700,647	$36,713,902
3	EOLS	Evolus, Inc. This page	2,630,665	$18,256,815

All Filings in EOLS

Export CSV

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$18,256,815	2,630,665	0.0%	Shares	Sole	2026-08-14
2026-03-31	$10,812,033	2,630,665	0.0%	Shares	Sole	2026-05-15
2025-12-31	$17,493,922	2,630,665	0.0%	Shares	Sole	2026-02-13
2025-09-30	$16,152,283	2,630,665	+8.0%	Shares	Sole	2025-11-14
2025-06-30	$22,431,415	2,435,550	—	Shares	Sole	2025-08-14
No filing history on record for this holder in this stock.